[ 18 F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy.
Jinbo GuiMengting LiJia XuXiao ZhangHeng MeiXiaoli LanPublished in: European journal of nuclear medicine and molecular imaging (2024)
F]FDG PET/CT can identify DLBCL patients who will benefit most from CAR T-cell therapy, and the value before CAR T-cell infusion may predict its toxicity in advance.